Royalty Pharma PLC (NASDAQ:RPRX)
| 38.69 Delayed Data As of Jan 27 |  -0.25 / -0.64%Today’s Change | 34.86 Today|||52-Week Range 52.98 | -2.91% Year-to-Date |
Latest RPRX News | Press Releases
| Oxler Private Wealth LLC Buys Ford Motor Co, Verizon Communications Inc, Zoom Video ... Jan 27 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 38.93 |
| Today’s open | 39.17 |
| Day’s range | 38.54 - 39.87 |
| Volume | 1,351,239 |
| Average volume (3 months) | 1,965,803 |
| Market cap | $23.8B |
Data as of 4:00pm ET, 01/27/2022
Growth & Valuation
| Earnings growth (last year) | -59.54% |
| Earnings growth (this year) | +16.70% |
| Earnings growth (next 5 years) | +11.05% |
| Revenue growth (last year) | +16.98% |
| P/E ratio | 20.0 |
| Price/Sales | 8.85 |
| Price/Book | 3.16 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | February 15, 2022 |
| EPS forecast (this quarter) | $0.77 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $975.0M |
| Net profit margin | 45.94% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
